Result of the clinical study “Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy“.

The objective of the one–year study was to assess the efficacy and safety of treatment with CombiNERV® (1 tablet a dat) in patients with type 2 Diabetes Mellitus and Diabetic Neuropathy.

*Didangelos T, Karlafti E, Kotzakioulafi E, Kontoninas Z, Margaritidis C, Giannoulaki P, Kantartzis K. Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy. Nutrients. 2020 Oct 23;12(11):3254. doi: 10.3390/nu12113254. PMID: 33114210; PMCID: PMC7690794.

Back